BioAdaptives, Inc. is a U.S.-based nutraceutical and medical-device marketing company focused on natural plant, fungi, algal, and cyanobacteria-based products. The company develops, markets, and distributes wellness products aimed at humans and animals, with emphasis on pain relief, anti-viral support, anti-aging, nootropics, weight control, and relaxation. It also markets the FDA-cleared Lung Flute™ device and has expanded its product rights through a 2024 transaction to support broader commercialization. BioAdaptives currently operates with a very lean structure, relying heavily on digital marketing, affiliates, telehealth partnerships, and outsourced support rather than in-house manufacturing.
−5 679,9 %
68,4 %
−8 523,4 %
+44,3 %
0.09
0.07
| % | |
|---|---|
| Nutraceutical supplements | 70% Natural supplement products based on plant, fungi, algal, and cyanobacteria ingredients for wellness use. |
| Medical device marketing | 20% Commercialization and distribution of the Lung Flute™ and related respiratory wellness devices. |
| Digital direct-to-consumer sales | 10% Online marketing and sales activities that convert health-conscious consumers through the company website and social channels. |
BioAdaptives sells primarily to health-conscious consumers who buy supplements for wellness, relaxation, weight...
Individuals purchasing supplements online for anti-aging, relaxation, pain relief, nootropics, and general wellness support.
Participants in virtual care ecosystems who are offered BioAdaptives products as companion or standalone wellness solutions.
Clinics, pharmacies, and medical communities that may adopt the Lung Flute™ for respiratory wellness use cases.
Gyms, athletic clubs, and senior communities targeted for wellness and respiratory support products.
BioAdaptives is headquartered in Las Vegas, Nevada, and operates as a U.S.-based company...
BioAdaptives is repositioning its product line and stated that it began introducing new products in the second quarter...
The company is trying to refresh its offering mix to improve relevance and sales traction in a crowded supplement market.
Revenue depends on converting online traffic and affiliate reach into sales, so marketing effectiveness is central to growth.
Broader distribution could diversify revenue away from pure DTC supplement sales and improve product credibility.
The company needs external funding to support operations, inventory, and growth initiatives while remaining a going concern.
BioAdaptives faces substantial going-concern risk because its business model requires ongoing financing to fund...
Management states that future operations likely require equity issuance, debt increases, or both, and there is substantial doubt about the company's ability to continue as a going concern.
The company must avoid health, drug, or disease-cure claims for its nutraceutical products, and misstatements could affect its ability to market products.
Sales depend heavily on DTC digital ads, affiliates, and social media, which can be volatile and expensive to scale.
Active ingredients are sourced worldwide from external suppliers, creating exposure to quality, availability, and compliance issues.
The company does not expect to build direct manufacturing capability and must rely on purchased finished products and licensing arrangements.
BIOA · Pharmaceutical Preparations
XAIR · Surgical & Medical Instruments & Apparatus
ADPT · Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp is a Seattle-based life sciences company built around immune-system sequencing and computational biology.
BRTX · Services-Misc Health & Allied Services, NEC
BHVN · Pharmaceutical Preparations
BIOE · Pharmaceutical Preparations
Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services.
: 11/08/2026